Summary: Recombinant DNA techniques offer the possibility of diagnosing genetic defects directly by analysing DNA itself. This is especially interesting for detecting carriers of recessive defects. In comparison with phenotypic screening with progeny testing or biochemical tests, DNA screening is independent of the time of gene expression and is not influenced by non-genetic effects. If the mutation causing the defect is known, alterations of DNA sequences can be identified directly as restriction fragment length polymorphisms (RFLPs) or with the use of allele specific oligonucleotides (ASO). DNA amplification with the polymerase chain reaction makes screening tests faster and more accurate. For most defects, the genetic basis is not known. Pedigree analysis with linked polymorphic DNA markers can be used to establish defect diagnosis. Linkage analysis can locate the chromosomal region of the gene responsible for the disease. Identification of the gene and the mutation in the defect allele finally will lead to direct DNA diagnosis. A dense linkage map with highly polymorphic genetic markers covering the entire genome will in future improve understanding of polygenic diseases. Increasing knowledge of the molecular genetics of human defects will promote DNA diagnosis in other species.
INTRODUCTION
Genetic defects are caused by a change in genetic information that results in an altered expression of one or more genes. In chromosomal disorders this change is already visible in the karyotype: the chromosomes show an abnormal arrangement or the number of chromosomes is altered. But in most inherited defects, the mutation affects only a small region of DNA, which must be detected by analysing DNA at the molecular level.
Disorders are initially supposed to be genetically determined because they run in families. If they show a simple Mendelian pattern of inheritance, they are generally determined by mutation of a single gene. But the phenotype can also be modified by exogenous factors. Such non-genetic factors may mask the monogenic pattern of inheritance. For these multifactorial disorders, it is difficult to identify each factor and its specific role in pathogenesis. This also holds true for polygenic disorders, where several genes are involved. Great progress has been made in understanding the molecular basis of monogenic diseases mainly caused by mutation of a single gene. For the control of these defects, biotechnology and especially recombinant DNA techniques offer new and powerful methods to screen DNA itself.
A monogenic disorder can be inherited in an autosomal or sex-linked fashion, depending on the chromosome on which the affected gene is located. Dominant diseases are already manifest in the heterozygous state, whereas recessive conditions are clinically apparent only when an individual carries the defective allele on both chromosomes. In sex-linked diseases in mammals, the affected genes are located on the X-chromosome. They can show dominant or recessive expression only in females (the homogametic sex). Males exhibit the defect whenever they inherit the mutant allele because they have only a haploid set of the X-located genes. The control of recessive defects causes problems because the heterozygous animals (carriers) are clinically normal but are able to transmit the defective gene to their offspring. In these cases, the frequency of the defective allele is efficiently reduced only when selection is carried out against both affected animals and carriers (24) .
PHENOTYPIC SCREENING
Today control programs for monogenic disorders in farm animal populations are based on detection of the defective gene at different levels of gene expression.
Clinical screening
In the case of a dominant disorder, culling of clinically affected individuals will eliminate the defective allele within one generation. In contrast, the control of recessive disorders requires the efficient detection of carrier animals. Test mating programs are usually conducted to identify carriers through affected progeny. If the frequency of the defective allele in the population is high, it suffices to breed the putative carrier to a random sample of the population, as in the case of arachnomelia in German Brown cattle (5) . In this population, gene frequency for the autosomal recessive gene was estimated as q = 0.047. For carrier screening with an error probability lower than 1%, recordings from 162 calves per sire are needed. Planned matings with known carriers would reduce the required number of offspring to 16. If the defect is not lethal, test matings to affected homozygous individuals may be conducted as is done in the case of mule foot in cattle (16) .
Mathematical calculations concerning sample size of test mating programs have been described by several authors (10, 24, 35) .
Modern reproductive technologies have been exploited in an attempt to reduce time and costs of progeny testing. Multiple ovulation, embryo transfer and artificial termination of pregnancy, are carried out for the diagnosis of tibial hemimelia in Galloway cattle (26) , bovine syndactyly in Holstein cattle (16) and arachnomelia in Swiss Brown cattle (7) . Nevertheless, progeny testing prolongs the generation interval and planned matings require the maintenance of test herds.
Biochemical screening
There are some examples where individuals at risk can be screened directly with a biochemical test that analyses the affected gene product or its metabolic effect (e.g. accumulation of substrate in enzymopathies).
Mannosidosis in cattle (17) and goats (19) is due to a deficiency of a-and ß-mannosidase, respectively. Because heterozygotes have one normal and one defective gene, they have enzyme activity levels in blood plasma approximately half the normal value. A similar gene dosage effect has been documented in cattle for a deficiency in uridinemonophosphate-synthase (30) and in sheep for lysosomal ß-galactosidase defect (1) . An example of carrier detection on the basis of substrate accumulation is bovine protoporphyria. Protoporphyrin accumulates in erythrocytes because ferrochelatase activity is reduced (18) , and erythrocyte protoporphyrin levels can be measured to distinguish between normal homozygous and heterozygous genotypes.
Biochemical screening can cause doubtful cases, because biochemical factors are usually subject to other, non-genetic sources of variation, such as age, season and feeding. This may result in overlapping distributions of normal and heterozygous values, e.g. for a-mannosidase activity in mannosidosis of cattle (18) . The application of biochemical screening is also restricted in X-linked recessive diseases as a consequence of random inactivation of the X-chromosome (24) . Some cells of a heterozygous female will produce the normal, and some cells the defective gene product. Therefore, the effectiveness of carrier detection depends on the proportion of mutant and normal X-chromosomes that are active in the individual at risk.
DNA SCREENING
The disadvantages of carrier screening on the level of gene expression can be overcome by identifying alterations of the genetic information itself. Recent advances in molecular biology have raised the possibility of visualising very small changes in the DNA sequence, even a change in a single base pair. In addition, DNA screening encompasses mutations of non-coding regions of the genome, regions which are not translated into protein or even not transcribed into messenger RNA. A portion of this non-coding DNA contains regulatory elements. Several human inherited diseases have been shown to be caused by mutations in non-coding sequences.
DNA screening can be based on direct detection of the mutation or on linkage analysis using polymorphic DNA markers.
Direct diagnosis
Direct diagnosis is limited to genetic diseases whose molecular basis is well understood and where the underlying mutation is known. The normal function of a single gene can be destroyed by a change in DNA sequence arising from a single base pair change (point mutation) or from deletion, insertion or inversion of a DNA fragment. Gene deletions or insertions often lead to complete failure to produce the relevant protein. Single base pair changes can result in amino acid substitution in the polypeptide sequence, create a stop signal for translation (nonsense codon) or disturb RNA transcription or processing. The molecular pathology of the human thalassaemia syndromes has been intensively studied and gives an excellent overview of the possible causes of monogenic defects (2).
In order to identify the particular gene of interest, a segment of DNA which is known to code for a part of the gene is used as a probe. In a hybridisation experiment, this DNA probe is made radioactive and allowed to search out and bind to its complementary sequence in a pool of single-stranded total genomic DNA of the individual of interest. Exposure to an X-ray film visualises the DNA fragments that contain sequences complementary to the labelled gene probe.
A method that detects deletions, insertions and some of the point mutations in the region which surrounds the gene probe is called Southern blotting (34) (Fig. 1) . Genomic DNA, isolated usually from a blood sample, is digested with a restriction enzyme. These enzymes recognise a specific short sequence of DNA, usually four or six base pairs long, and cleave the double-stranded DNA molecule within this sequence. A restriction digest generates a continuum of fragments with a well-defined size distribution specific to each restriction enzyme. Digested DNA is then size fractionated on an agarose gel by electrophoresis, denatured to separate DNA duplexes and transferred to a filter paper. Hybridisation with the labelled DNA probe will visualise, on an X-ray film, fragments of a specific length containing sequences of the gene. This banding pattern will change if a deletion or insertion has occurred. A change in restriction fragment length pattern will also be seen if a restriction site has been destroyed or created through a single base pair mutation.
If different banding patterns occur in individuals of the same species, analysed with a given restriction enzyme/gene probe combination in a Southern blot experiment, this is called a restriction fragment length polymorphism (RFLP). Each banding pattern represents a different allele in homozygous, or the combination of two alleles in heterozygous, individuals. The mutant sickle cell globin gene carries a single base pair change from adenine to thymine compared to the normal ß-globin gene. This base pair change alters the sixth amino acid residue in the ß-globin protein from glutamic acid to valine. A recognition site for Ddel is thus destroyed, resulting in a single fragment of 376 base pairs in the Southern blot, rather than two smaller fragments of 201 and 175 base pairs found in the normal allele.
Unfortunately, most point mutations are not detectable as RFLPs. If the base pair change and nucleotide sequence surrounding the mutation is known, this problem can be solved by using allele specific oligonucleotides (ASO) as hybridisation probes. This technique has been established for the diagnosis of sickle cell anaemia (9) . Two short pieces of DNA (oligonucleotides), each 19 base pairs long, were synthesized; these encompassed the region of point mutation. One is complementary to the normal human ß-globin allele and the other is complementary to the sickle cell allele (Fig. 2-II) . Under appropriate hybridisation conditions, each ASO probe detects only the completely homologous sequence in total single-stranded genomic DNA dotted on a piece of filter paper. This dot-blot analysis makes it possible to distinguish the three possible genotypes.
Southern blotting and the use of ASO probes both require relatively high amounts allows genetic disorders to be diagnosed with greater speed and accuracy. PCR is an in vitro method which amplifies a specific DNA sequence more than a millionfold within a few hours (31, 32) . To carry out PCR, the flanking sequences of the fragment of interest must be known so that oligonucleotides, which serve as primers homologous to opposite strand ends, can be constructed. Instead of analysing great amounts of whole genomic DNA, only the target sequence surrounding the mutation is amplified and analysed. This gives a greater accuracy in dot-blot experiments with ASO probes and reduces conventional Southern blotting to restriction digestion of the amplified product and determination of fragment size with gel electrophoresis. Detailed applications of PCR to the diagnosis of human monogenic diseases have been described (20) . PCR can also be used to amplify DNA from a single cell, which makes it possible to analyse specific genes in preimplantation embryos (3).
Linkage analysis
For many inherited defects the genetic basis is not known. In several human genetic diseases, carrier diagnosis could be established with polymorphic DNA markers which are linked to the disease locus (6) . Gene probes which identify RFLPs are used to search for a banding pattern that cosegregates with the defect. This has been accomplished for congenital goiter in Africander cattle (29) and in goats (21) , where an RFLP allele was detected with a thyroglobulin gene probe that is associated with the disease allele (Fig. 3) . Previous analysis of goitrous Africander cattle showed aberrant splicing of their thyroglobulin pre-mRNA (28) . Southern blot analysis of Pstl-digested DNA with a thyroglobulin cDNA probe detects fragments of 1400 and 1000 base pairs (bp) in normal animals. In goitrous animals the 1000 bp fragment is replaced by a fragment of 880 bp. Animals heterozygous for the goiter allele show, in addition to the 1400 bp fragment, two fainter bands of 1000 and 880 bp in length. 
heterozygous (AG) and goitrous (GG) animals
For many inherited disorders, however, there is no hint of the affected gene. In these cases, a strategy called reverse genetics may be applied (13, 14) . Linkage analysis is conducted with random single-copy DNA sequences capable of detecting DNA polymorphisms (4) . Ideally these probes should show a high degree of polymorphism and should be well distributed over the entire genome. RFLPs due to single base mutations are mostly diallelic. Their usefulness for linkage analysis is limited because only matings between heterozygous individuals with respect to the marker locus provide linkage information (25) ; the expected frequency of heterozygosity at a marker locus is directly related to the number of common alleles in a population. Another type of RFLPs arises from a variation of repeated sequences. These sequences are highly polymorphic because of variation in the copy number of the repeated elements (VNTRs = variable number of tandem repeats) (23) . These probes recognise RFLPs when genomic DNA is digested with a restriction enzyme that does not cut within the repeated sequence (Fig. 4) .
Linkage analysis with a polymorphic VNTR marker near the a-globin gene cluster has been conducted for human adult polycystic kidney disease (APCKD) (27) . Pedigree analysis revealed that most affected individuals carried a specific VNTR marker allele C. From these data, the recombination frequency between the a-globin gene and the APCKD locus was estimated to be 0.05.
Once some association for a DNA probe has been found, other probes closer to the gene of interest can be isolated through chromosome walking and jumping (8) . This will improve the accuracy of carrier detection and may finally lead to the identification of the affected gene, as happened in the cases of haemophilia A (12) and cystic fibrosis (15) . The nature of the disease then may be identified from the sequence of the gene and the gene alterations found in defective individuals. The identification of the DNA sequence change responsible for the defect is the last step in establishing a direct diagnosis for a genetic disease as described above. Figure 5 summarises the steps of the reverse genetics approach, which in the case of cystic fibrosis took several years of scientific work (16) .
The human genetic linkage map
Polymorphic DNA markers, which can be used as a label for the region surrounding them on the chromosome, may make it possible to trace the segregation of this region from generation to generation. Linkage relationships among genetic markers can be determined by estimating recombination frequencies between pairs of loci during meiosis (25) . The aim of a genetic linkage map is to establish a set of evenly spaced, highly polymorphic markers covering the entire genome (4). In humans great progress has been made towards such a linkage map (11) using a set of 21 three-generation families with large sibships. With a dense linkage map, several regions (loci) on the chromosomes can be analysed simultaneously (22) . In the future this should also improve the understanding and control of genetic defects that involve more than one gene.
CONCLUSION
In the future more genetic defects will arise because in modern breeding systems, the influence of individual sires is steadily increasing, especially in breeds where population size is small. This increases the danger of rapidly spreading an unknown The reverse genetics approach defect which will not occur at higher incidence until the first sons of the carrier male come into service (e.g. arachnomelia in German and Swiss Brown cattle) (5, 7).
It is expected that every individual carries several defect alleles. Breeding animals should be evaluated considering all their characteristics, including both the positive and the negative ones. Control of genetic diseases does not mean that every carrier must be killed. For example, recessive defects can also be prevented if matings among carriers are avoided. The decision on how to control genetic defects in breeding plans depends on the nature of the disease. Frequency and severity of the defect, economic loss, as well as costs and possibilities for a screening program should be taken into consideration (10, 18) .
Recombinant DNA techniques for the first time offer the possibility of diagnosing a genetic disease directly at the genetic level. This diagnosis is independent of the time of gene expression and is not influenced by non-genetic effects. There is no general way to establish such a test, and a specific strategy must be chosen for each disease. So far, DNA diagnosis in farm animals is only possible for congenital goiter in cattle and goats. Nevertheless, increasing knowledge of the molecular basis of human genetic diseases will promote and accelerate the development of DNA screening in other species (33) . Resumen: Las técnicas del ADN recombinante permiten diagnosticar las anomalías genéticas directamente, por análisis del ADN, lo que es especialmente interesante para detectar los portadores de genes recesivos. Comparada con el estudio del fenotipo por la prueba de la descendencia o por exámenes bioquímicos, esta técnica presenta la ventaja de no tener que esperar la expresión del gene y no ser influenciada por efectos no genéticos. Si la mutación causante de la anomalía es conocida, las alteraciones de las secuencias de ADN pueden identificarse directamente por análisis de los polimorfismos de la longitud de los fragmentos de restricción (RFLP) o bien empleando oligonucleótidos alélicos específicos (ASO). Gracias a la amplificación del ADN resultante de la reacción de amplificación enzimàtica (PCR), las pruebas de diagnóstico son más rápidas y fiables. En la mayoría de casos, el origen genético de la anomalía no es conocido, pero es posible establecer un diagnóstico de anomalías genéticas analizando ascendientes con sondas de ADN enlazadas. El análisis de los enlaces puede localizar la región cromosomica en que se encuentra el gene responsable de la anomalía. La identificación del gene y de la mutación generada en el alelo portador de la anomalía conducirá finalmente a un diagnóstico directo a partir del ADN. Una cartografía precisa de los enlaces, realizada con marcadores genéticos de una tasa de polimorfismo sumamente elevada, y distribuida por todo el genoma, permitirá una mayor comprensión de las enfermedades poligénicas. Los progresos de la genética molecular de las anomalías en el hombre fomentarán el uso de las técnicas del ADN para diagnosticar las enfermedades genéticas en otras especies.
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